Gevo, Inc. 4
4 · Gevo, Inc. · Filed Dec 18, 2013
Insider Transaction Report
Form 4
Gevo, Inc.GEVO
KISHORE GANESH
Director
Transactions
- Purchase
Common Stock
2013-12-16+370,370→ 2,041,795 total(indirect: See foonote) - Purchase
Common Stock
2013-12-16+37,037→ 89,295 total - Purchase
Common Stock Warrant (right to buy)
2013-12-16+37,037→ 37,037 totalExercise: $1.85From: 2013-12-16Exp: 2018-12-16→ Common Stock (37,037 underlying) - Purchase
Common Stock Warrant (right-to-buy)
2013-12-16+370,370→ 370,370 total(indirect: See footnote)Exercise: $1.85From: 2013-12-16Exp: 2018-12-16→ Common Stock (370,370 underlying)
Footnotes (2)
- [F1]The shares of common stock and the warrants to purchase common stock were purchased together as common stock units, but were issued separately. Each common stock unit consisted of one share of common stock and a warrant to purchase one share of common stock, at a public offering price of $1.35 per common stock unit. Each warrant has an exercise price of $1.85 per share (subject to adjustment in certain circumstances), became exercisable on the date of original issuance and will expire on December 16, 2018.
- [F2]The reporting person is deemed to be the beneficial owner of shares held by Malaysian Life Sciences Capital Fund Ltd. as previously reported on the Form 4 filed February 15, 2011.